404 results
Page 2 of 21
8-K
EX-99.1
9m5b63b1mns4oe
27 Jul 23
Baxter Reports Second-quarter 2023 Results
7:33am
8-K
EX-99.1
2cz8df00c2f7l hfs2
6 Jul 23
Regulation FD Disclosure
8:30am
8-K
EX-2.1
obs9c8zopcdzs
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am
8-K
EX-99.1
4ojtcoaqzif
27 Apr 23
Baxter Reports First-quarter 2023 Results
7:18am
8-K
EX-99.1
ael2zb3apqano8u5sae
27 Oct 22
Baxter Reports Third-quarter 2022 Results
7:18am
8-K
EX-99.1
7les8 m0xa1zv6z
30 Sep 22
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-99.1
w74v ic2mq0
28 Jul 22
Baxter Reports Second-quarter 2022 Results
7:19am
8-K
EX-99.1
2pybe2w0cre wr
25 May 22
Baxter Highlights Business Strategies and Innovation
9:11am
8-K
EX-99.1
h8s2q6x2q
28 Apr 22
Baxter Reports First-quarter 2022 Results
7:19am